Value202020212022202320242025TTMCash from investing activities-75.51 M-26.74 M4.3 M7.37 M-53.97 M3.56 M1.8 MCash from financing activities102.37 M-4.68 M-7.62 M-23.27 M-6.57 M-1.15 M-1.43 MFree cash flow8.33 M14.63 M13.93 M18.18 M9.56 M14.78 M20.13 M
Simulations Plus Inc
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.